ESPR Esperion Therapeutics, Inc.
Healthcare$3.13+0.00%OpenMarket Cap: $649.7M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$3.19
Target (Median)
$3.16
Target Range
$3.16 - $3.28
Upside from current price: 2.1%
Rating Distribution
3 Strong Buy3 Buy6 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-04 | Needham | downgrade | Hold | Buy |
| 2026-05-01 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-03-13 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-03 | Needham | maintain | Buy | Buy |
| 2025-09-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-17 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.27 | $448.8M | 4 |
| Sun Dec 31 | $0.55 | $553.2M | 4 |
| Mon Dec 31 | $1.17 | $884.5M | 2 |
| Tue Dec 31 | $1.67 | $1.12B | 2 |